These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 33715901

  • 1. Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes.
    Amin-Chowdhury Z, Groves N, Sheppard CL, Litt D, Fry NK, Andrews N, Ladhani SN.
    Vaccine; 2021 Apr 01; 39(14):1997-2004. PubMed ID: 33715901
    [Abstract] [Full Text] [Related]

  • 2. Characteristics of Children With Invasive Pneumococcal Disease After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine in England and Wales, 2010-2016.
    Makwana A, Sheppard C, Borrow R, Fry N, Andrews NJ, Ladhani SN.
    Pediatr Infect Dis J; 2018 Jul 01; 37(7):697-703. PubMed ID: 29889811
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018.
    Andrews N, Kent A, Amin-Chowdhury Z, Sheppard C, Fry N, Ramsay M, Ladhani SN.
    Vaccine; 2019 Jul 26; 37(32):4491-4498. PubMed ID: 31272872
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of Invasive Pneumococcal Disease Caused by Emerging Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in England: A Prospective Observational Cohort Study, 2014-2018.
    Amin-Chowdhury Z, Collins S, Sheppard C, Litt D, Fry NK, Andrews N, Ladhani SN.
    Clin Infect Dis; 2020 Nov 05; 71(8):e235-e243. PubMed ID: 31955196
    [Abstract] [Full Text] [Related]

  • 5. Whole genome characterization of Streptococcus pneumoniae from respiratory and blood cultures collected from Canadian hospitals before and after PCV-13 implementation in Canada: Focus on serotypes 22F and 33F from CANWARD 2007-2018.
    Golden AR, Adam HJ, Baxter M, Martin I, Demczuk W, Mulvey MR, Karlowsky JA, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    Vaccine; 2021 Sep 15; 39(39):5474-5483. PubMed ID: 34454785
    [Abstract] [Full Text] [Related]

  • 6. Mathematical modeling of pneumococcal transmission dynamics in response to PCV13 infant vaccination in Germany predicts increasing IPD burden due to serotypes included in next-generation PCVs.
    Horn M, Theilacker C, Sprenger R, von Eiff C, Mahar E, Schiffner-Rohe J, Pletz MW, van der Linden M, Scholz M.
    PLoS One; 2023 Sep 15; 18(2):e0281261. PubMed ID: 36791091
    [Abstract] [Full Text] [Related]

  • 7. Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study.
    Bertran M, D'Aeth JC, Abdullahi F, Eletu S, Andrews NJ, Ramsay ME, Litt DJ, Ladhani SN.
    Lancet Infect Dis; 2024 May 15; 24(5):546-556. PubMed ID: 38310905
    [Abstract] [Full Text] [Related]

  • 8. Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination.
    Grant LR, Slack MPE, Theilacker C, Vojicic J, Dion S, Reinert RR, Jodar L, Gessner BD.
    Clin Infect Dis; 2023 Feb 08; 76(3):e1062-e1070. PubMed ID: 35789262
    [Abstract] [Full Text] [Related]

  • 9. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study.
    Lo SW, Gladstone RA, van Tonder AJ, Lees JA, du Plessis M, Benisty R, Givon-Lavi N, Hawkins PA, Cornick JE, Kwambana-Adams B, Law PY, Ho PL, Antonio M, Everett DB, Dagan R, von Gottberg A, Klugman KP, McGee L, Breiman RF, Bentley SD, Global Pneumococcal Sequencing Consortium.
    Lancet Infect Dis; 2019 Jul 08; 19(7):759-769. PubMed ID: 31196809
    [Abstract] [Full Text] [Related]

  • 10. PCR-based discrimination of emerging Streptococcus pneumoniae serotypes 22F and 33F.
    Gillis HD, Demczuk WHB, Griffith A, Martin I, Warhuus M, Lang ALS, ElSherif M, McNeil SA, LeBlanc JJ.
    J Microbiol Methods; 2018 Jan 08; 144():99-106. PubMed ID: 29162393
    [Abstract] [Full Text] [Related]

  • 11. Distribution of serotypes causing invasive pneumococcal disease in older adults from high-income countries and impact of pediatric and adult vaccination policies.
    Grant LR, Slack MPE, Theilacker C, Vojicic J, Dion S, Reinert RR, Jodar L, Gessner BD.
    Vaccine; 2023 Aug 31; 41(38):5662-5669. PubMed ID: 37544825
    [Abstract] [Full Text] [Related]

  • 12. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.
    Balsells E, Guillot L, Nair H, Kyaw MH.
    PLoS One; 2017 Aug 31; 12(5):e0177113. PubMed ID: 28486544
    [Abstract] [Full Text] [Related]

  • 13. Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F.
    Golden AR, Adam HJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA).
    Vaccine; 2016 May 17; 34(23):2527-30. PubMed ID: 27085174
    [Abstract] [Full Text] [Related]

  • 14. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.
    Vaccine; 2013 Dec 16; 31(52):6232-8. PubMed ID: 24176490
    [Abstract] [Full Text] [Related]

  • 15. Invasive pneumococcal disease in Canada 2010-2017: The role of current and next-generation higher-valent pneumococcal conjugate vaccines.
    Dion SB, Major M, Gabriela Grajales A, Nepal RM, Cane A, Gessner B, Vojicic J, Suaya JA.
    Vaccine; 2021 May 21; 39(22):3007-3017. PubMed ID: 33824041
    [Abstract] [Full Text] [Related]

  • 16. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S, Menzies R, Chiu C, Toms C, Blyth CC, Krause V, McIntyre P.
    Clin Infect Dis; 2017 Jan 15; 64(2):175-183. PubMed ID: 27986682
    [Abstract] [Full Text] [Related]

  • 17. Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children.
    Kendall BA, Dascomb KK, Mehta RR, Stockmann C, Mason EO, Ampofo K, Pavia AT, Byington CL.
    Vaccine; 2016 Jan 20; 34(4):474-478. PubMed ID: 26706276
    [Abstract] [Full Text] [Related]

  • 18. Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014.
    Oligbu G, Collins S, Andrews N, Sheppard CL, Fry NK, Slack MPE, Borrow R, Ladhani SN.
    Clin Infect Dis; 2017 Oct 01; 65(7):1191-1198. PubMed ID: 29309553
    [Abstract] [Full Text] [Related]

  • 19. Invasive Pneumococcal Disease in UK Children <1 Year of Age in the Post-13-Valent Pneumococcal Conjugate Vaccine Era: What Are the Risks Now?
    Kent A, Makwana A, Sheppard CL, Collins S, Fry NK, Heath PT, Ramsay M, Ladhani SN.
    Clin Infect Dis; 2019 Jun 18; 69(1):84-90. PubMed ID: 30281069
    [Abstract] [Full Text] [Related]

  • 20. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.
    van Hoek AJ, Sheppard CL, Andrews NJ, Waight PA, Slack MP, Harrison TG, Ladhani SN, Miller E.
    Vaccine; 2014 Jul 23; 32(34):4349-55. PubMed ID: 24657717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.